共 8 条
[1]
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW,Hirsh J,Weitz JI,et al. Circulation . 2002
[2]
Increased platelet sensitivity to collagen in individuals resistant to lowdose aspirin. Kawasaki T,Ozeki Y,Igawa T,et al. Stroke . 2000
[3]
Platelet - active drugs: the relationships among dose, effectiveness, and side effects. Patrono C,Coller B,Dalen JE,et al. Chest .
[4]
Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Gum PA,Kottke-Marchant K,Poggio ED,et al. The American Journal of Cardiology . 2001
[5]
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin - like drugs. Vane JR. Nature New Biology . 1971
[6]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[7]
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Loll PJ,Picot D,Garavito RM. Natural Structural Biology . 1995
[8]
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Loll PJ,Picot D,Garavito RM. Natural Structural Biology . 1995